Resveratrol as an immune checkpoint inhibitor to enhance the efficacy of breast cancer immunotherapy.

Alamolhodaei NS, Hudson BI, Mosaffa F, Boozari M

DOI: 10.22038/ijbms.2026.93534.20178
Published: 2026
Container: Iranian journal of basic medical sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.22038/ijbms.2026.93534.20178,
  title = {Resveratrol as an immune checkpoint inhibitor to enhance the efficacy of breast cancer immunotherapy.},
  author = {Alamolhodaei NS and Hudson BI and Mosaffa F and Boozari M},
  year = {2026},
  journal = {Iranian journal of basic medical sciences},
  doi = {10.22038/ijbms.2026.93534.20178},
  url = {https://doi.org/10.22038/ijbms.2026.93534.20178}
}

RIS

TY  - JOUR
TI  - Resveratrol as an immune checkpoint inhibitor to enhance the efficacy of breast cancer immunotherapy.
AU  - Alamolhodaei NS
AU  - Hudson BI
AU  - Mosaffa F
AU  - Boozari M
PY  - 2026
JO  - Iranian journal of basic medical sciences
DO  - 10.22038/ijbms.2026.93534.20178
UR  - https://doi.org/10.22038/ijbms.2026.93534.20178
ER  -

APA

NS, A., BI, H., F, M., & M, B. (2026). Resveratrol as an immune checkpoint inhibitor to enhance the efficacy of breast cancer immunotherapy.. Iranian journal of basic medical sciences. https://doi.org/10.22038/ijbms.2026.93534.20178

Source records

pubmed · retrieved 2026-11-10T12:01:44.324Z